These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8113154)
1. Macrophages enhance binding of beta-VLDL and cholesterol ester accumulation in cultured aortic smooth muscle cells. Rennick RE; Campbell JH; Campbell GR Heart Vessels; 1994; 9(1):19-29. PubMed ID: 8113154 [TBL] [Abstract][Full Text] [Related]
2. Macrophages modify beta-VLDL by proteolysis and enhance subsequent lipid accumulation in arterial smooth muscle cells. Davis JB; Bowyer DE Atherosclerosis; 1989 Jun; 77(2-3):203-8. PubMed ID: 2751751 [TBL] [Abstract][Full Text] [Related]
3. Effect of endothelium on beta-VLDL metabolism by cultured smooth muscle cells of differing phenotype. Horrigan S; Campbell JH; Campbell GR Atherosclerosis; 1988 May; 71(1):57-69. PubMed ID: 3377880 [TBL] [Abstract][Full Text] [Related]
4. Can lipoprotein lipase be the culprit in cholesteryl ester accretion in smooth muscle cells in atheroma? Stein O; Ben-Naim M; Dabach Y; Hollander G; Halperin G; Stein Y Atherosclerosis; 1993 Feb; 99(1):15-22. PubMed ID: 8461056 [TBL] [Abstract][Full Text] [Related]
5. Effect of conditioning of beta-migrating very low-density lipoprotein with macrophages on the accumulation of cholesteryl esters in smooth muscle cells. Nishide T; Morisaki N; Shirai K; Saito Y; Yoshida S Scand J Clin Lab Invest; 1992 Apr; 52(2):129-36. PubMed ID: 1589699 [TBL] [Abstract][Full Text] [Related]
6. Murine macrophages secrete factors that enhance uptake of non-lipoprotein [3H]cholesteryl ester by aortic smooth muscle cells. Stein O; Ben-Naim M; Dabach Y; Hollander G; Stein Y Biochim Biophys Acta; 1994 Jun; 1212(3):305-10. PubMed ID: 8199201 [TBL] [Abstract][Full Text] [Related]
7. Long-term treatment of neonatal aortic smooth muscle cells with beta VLDL induces cholesterol accumulation. Schreiber BM; Jones HV; Toselli P; Franzblau C Atherosclerosis; 1992 Aug; 95(2-3):201-10. PubMed ID: 1418093 [TBL] [Abstract][Full Text] [Related]
8. Macrophage-conditioned medium and beta-VLDLs enhance cholesterol esterification in SMCs and HSFs by LDL receptor-mediated and other pathways. Stein O; Dabach Y; Ben-Naim M; Hollander G; Stein Y Arterioscler Thromb; 1993 Sep; 13(9):1350-8. PubMed ID: 8364019 [TBL] [Abstract][Full Text] [Related]
9. Beta-VLDL-induced cholesterol ester deposition in macrophages may be regulated by neutral cholesterol esterase activity. Ishii I; Oka M; Katto N; Shirai K; Saito Y; Hirose S Arterioscler Thromb; 1992 Oct; 12(10):1139-45. PubMed ID: 1390586 [TBL] [Abstract][Full Text] [Related]
10. Oxidation of beta-very low density lipoprotein by endothelial cells enhances its metabolism by smooth muscle cells in culture. Horrigan S; Campbell JH; Campbell GR Arterioscler Thromb; 1991; 11(2):279-89. PubMed ID: 1900191 [TBL] [Abstract][Full Text] [Related]
11. Interaction between macrophages and aortic smooth muscle cells. Enhancement of cholesterol esterification in smooth muscle cells by media of macrophages incubated with acetylated LDL. Stein O; Halperin G; Stein Y Biochim Biophys Acta; 1981 Sep; 665(3):477-90. PubMed ID: 7295747 [TBL] [Abstract][Full Text] [Related]
12. beta-VLDL and acetylated-LDL binding to pigeon monocyte macrophages. Henson DA; St Clair RW; Lewis JC Atherosclerosis; 1989 Jul; 78(1):47-60. PubMed ID: 2667527 [TBL] [Abstract][Full Text] [Related]
18. Macrophage interaction with very-low-density lipoproteins results in triacylglycerol-enriched smooth muscle cells. Bergstraesser LM; Bates SR Biochim Biophys Acta; 1985 Oct; 836(3):296-305. PubMed ID: 4041472 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E is the determinant that mediates the receptor uptake of beta-very low density lipoproteins by mouse macrophages. Innerarity TL; Arnold KS; Weisgraber KH; Mahley RW Arteriosclerosis; 1986; 6(1):114-22. PubMed ID: 3942555 [TBL] [Abstract][Full Text] [Related]
20. Foam cells in explants of atherosclerotic rabbit aortas have receptors for beta-very low density lipoproteins and modified low density lipoproteins. Pitas RE; Innerarity TL; Mahley RW Arteriosclerosis; 1983; 3(1):2-12. PubMed ID: 6297442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]